---
schema_version: "secwatch.filing_event.v1"
accession: "0001213900-26-081377"
form_type: "8-K"
ticker: "VIVS"
cik: "0001497253"
company_name: "VivoSim Labs, INC."
filed_at: "2026-07-24T20:07:32+00:00"
generated_at: "2026-07-24T20:08:11.852206+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.75
calibrated_materiality_score: 0.75
confidence: "high"
source: SEC EDGAR
---

# VivoSim Labs receives Nasdaq delisting notice; subsequent transactions restore equity above $2.5M

## Summary
- Received Nasdaq delisting notice on July 20, 2026 for failing to maintain $2.5M minimum stockholders' equity; equity was $(1,099,000) as of March 31, 2026.
- Company has 45 days (until Sept 3, 2026) to submit a compliance plan; Nasdaq may grant up to 180-day extension.
- Subsequent transactions boosted equity above $2.5M: $5M milestone from Eli Lilly, $4M private placement, and $5.1M from warrant exercises.
- As of filing, stockholders' equity exceeds $2.5M and shares outstanding are 12,057,789.
- No immediate effect on listing; stock continues trading under VIVS on Nasdaq Capital Market.

## SEC filing metadata
- accession: 0001213900-26-081377
- form_type: 8-K
- ticker: VIVS
- cik: 0001497253
- company_name: VivoSim Labs, INC.
- filed_at: 2026-07-24T20:07:32+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.75
- calibrated_materiality_score: 0.75
- confidence: high
- sec_items: 3.01, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1497253/000121390026081377/0001213900-26-081377-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1497253/000121390026081377/ea0299224-8k_vivo.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001213900-26-081377
- JSON: https://secwatch.observer/filing/0001213900-26-081377.json
- Plain text: https://secwatch.observer/filing/0001213900-26-081377.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.